111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
4.050
-0.032 (-0.78%)
Nov 13, 2025, 4:00 PM EST - Market closed
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $35.1 million as of November 14, 2025. Its market cap has decreased by -46.78% in one year.
Market Cap
35.10M
Enterprise Value
2.36M
1-Year Change
-46.78%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $35.10M, a decrease of -96.85%. That is a compound annual growth rate of -38.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 35.38M | -33.71% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | 572.40M | 4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 902.99B |
| Johnson & Johnson | 469.88B |
| AbbVie | 410.40B |
| UnitedHealth Group | 308.09B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 227.82B |
| Abbott Laboratories | 223.18B |